STUDIES IN CUSHING'S SYNDROME. II (Submitted for publication June 28, 1957 ; accepted July 25, 1957) Patients with Cushing's syndrome due to bilateral adrenal cortical hyperplasia have been reported by several investigators to show an exaggerated plasma 17-hydroxycorticosteroid response to administered ACTH (1) (2) (3) . Although pituitary corticotropin has been suspected of playing an etiologic role in this disorder, previous workers have generally failed to detect elevated levels of ACTH in the blood of patients with Cushing's syndrome (4) (5) (6) (7) . Furthermore, the prolonged administration of ACTH to normal subjects has not been observed to cause adrenal cortical hyperresponse comparable to that found in bilateral adrenal hyperplasia (8, 9) .
In search of an explanation for this adrenal hyper-responsiveness, the possibility has been investigated of another type of corticotropic activity, different from the usual ACTH (10) (11) (12) . The purpose of this communication is to present data which indicate the occurrence of adrenal weight-maintaining activity in the plasma of patients with Cushing's syndrome associated with adrenal hyperplasia.
METHODS AND MATERIALS
Plasma for assay was obtained from several groups of patients (vide infra) in the following manner.
Samples of 100 to 200 ml. of blood were collected in iced tubes with heparin added, plasma was quickly separated in a cold centrifuge, and then frozen and stored at -20°C. in small tubes containing sufficient material (6 to 9 ml.) for a single day's injection. In three instances, plasma was lyophilized and reconstituted with distilled water to the original volume. tropic activity was measured by the ability of a substance to prevent adrenal atrophy in the rat following hypophysectomy (13) . Male Sprague-Dawley rats were hypophysectomized at 30 days of age. Injections of the plasma to be assayed were begun 24 hours later. The dosage of plasma was 0.3 ml. given subcutaneously three times a day for nine days, making a total dose of 8 to 9 ml. per rat. Plasma from each individual patient (or in some instances, from each plasma pool, vide infra) was administered to a group of six to nine rats. The control for each group of experimental rats was a group of six to ten animals of exactly the same age, hypophysectomized on the same day, and maintained identically throughout each experimental period, except that no injections were given. As an additional control for patients' plasma, groups of hypophysectomized rats were given plasma from normal human subjects (vide Results, Section 3). On the tenth day, animals were sacrificed. The adrenals were removed, dissected free of fat, wet-weighed, fixed in formalin, stained with Sudan Black, and sectioned for histologic study. Completeness of hypophysectomy was estimated by testicular size, and in six instances, by gross examination of the sella. All animals judged to be incompletely hypophysectomized were discarded. RESULTS 
Bilateral adrenal hyperplasia
Plasma for assay was obtained from nine patients with this disease. All showed the typical clinical and laboratory features of Cushing's syndrome. In six patients, the diagnosis of adrenal hyperplasia was proved at operation, and in the remaining three (N.Co., R.P., B.S.) no adrenal tumor was detected by presacral aerography. Eight of the nine patients (with the exception of S.A.) showed the typical plasma 17-hydroxycorticosteroid hyper-response to a standardized ACTH test (2, 9) . Table I shows results of the assay for adrenal weight-maintaining activity in the plasma of these nine patients. Eight of the nine plasma specimens (with the exception of patient B.S.) were found to prevent adrenal atrophy to a significant degree. 1608 Since the numbers of animals were necessarily small (being limited by the amount of plasma available) ,data from individual experiments were pooled for additional statistical analysis. The average difference in adrenal weight between injected and noninjected animals was 2.7 mg. with a "t" value of 7.4 (Table I) . The difference was significant at the 1 per cent level. It was of interest that injected animals in this and subsequent groups generally showed greater final body weights than uninjected animals, the difference averaging about 6 Gm. (In this group, average weight gain of injected animals was 9 Gm.; of uninjected controls, 4 Gm.) This was true regardless of whether the plasma contained any activity in maintaining adrenal weight or not. Calculation of the average correlation coefficient between body weight and adrenal weight gave an "r" value of 0.289, which is not significant (average slope, 0.04). The greater final body weight of injected animals could thus account for only about 0.2 mg. of the 2.7 mg. difference in adrenal weights.
It is recognized that the degree of adrenal weight maintenance is modest, with an average adrenal weight of 10.1 mg. in injected animals as compared with 7.4 mg. in the controls. However, when similarly hypophysectomized animals were injected with a standard ACTH preparation in massive doses, i.e., 1 I.U. daily in three divided doses for nine days, adrenal weight averaged only 14.9 mg. Further, corticotropic material has been estimated to be present in amounts of the order of milliunits or fractions of milliunits per 100 ml. of human plasma (5, 14, 15) , and each experimental animal in the present study received but 8 to 9 ml. plasma.
Histologic study of adrenal glands from animals injected with plasma revealed persistence of the sudanophobic zone, which was abolished by ACTH administration.
Studies performed in two patients (F.S. and H.H.) employing three animals in each assay failed to reveal adrenal ascorbic acid-depleting activity in plasma when tested by the Munson modification (16) of the Sayers technique (17).
Adrenal cortical tumor
The data obtained from the assay of plasma from three patients with documented adrenal cortical adenoma or carcinoma are shown in Table II t The greater adrenal weights found in the study of plasma from patient V. C. may be related to the fact that this experiment was terminated after seven days of inijeetion instead of nine days because of a large number of animal deaths.
Post-hypophysectomy atrophy of the adrenal would not be expected to have reached its plateau within a seven day period.
standardized ACTH test (9) , and no adrenal weight-aintaing activity could be demonstrated in their plasma. 3 . Normal subjects Table III shows results of the assay of plasma from normal individuals. The first specimen was taken from a single normal subject, while the remaining three specimens were pools of approximately equal plasma samples taken from three to five normal individuals. -No significant increase of adrenal weight could be shown in the injected animals. Grouped data revealed an average difference in adrenal weight of injected versus uninjected animals of 0.05 mg. with a "t" value of 0.19 (not significant).
Primary adrenal cortical isufficiewcy
A summary of the results of assay of plasma from patients with adrenal insfriec either spontaneous or following bilateral total adrenalectomy, is shown in Table IV . Mast assay methods have shown elevated levels of corticotropin in the blood of such patients (4-6, 18). It was therefore of interest to learn if plasma from adrenal-insufficient subjects also contained adrenal weight-maintaining activity. Blood was obtained and plasma pooled from five such patients whose exogenous steroid (cortisone) had been discontinued six to eight hours before blood was taken. Table IV shows that no adrenal weight-maintaining activity was detectable. This experiment does not offer conclusive evidence for the absence of adrenal 4 There is evidence that this "excessive response' may pregnancy had been previously shown to exhibit be in part related to a delayed disposal of hydrocortiexaggerated plasma 17-hydroxycorticosteroid ire-sone from plasma of pregait women (19, 20) . also made in two patients with "active" acromegaly. Table VI shows significant adrenal weight-maintaining activity in the plasma of both patients. It should be pointed out that neither of these two subjects had exaggerated plasma corticosteroid responses to ACTH.
Growth hormone
Investigation of the effect of bovine growth hormone (supplied by the National Institutes of Health) was carried out. Three mg. of this preparation were administered daily to a group of hypophysectomized rats, the adrenal weight assay being carried out as described above. The data presented in Table VII indicate that this growth hormone preparation contained significant adrenal weight-maintaining activity (p < 0.01) as previously demonstrated (10) (11) (12) . The sudanophobic zone of the adrenal cortex persisted. One mg. of this somatotropin contained no corticotropic activity, as determined by the method of Saffran and Schally (21).
DISCUSSION
The data presented indicate that plasma from patients with Cushing's syndrome due to bilateral adrenal hyperplasia exhibited adrenal weight-maintaining activity as demonstrated by assay in hypophysectomized rats. Plasma of pregnant women in the third trimester of pregnancy and of two patients with active acromegaly showed similar activity. It is not possible at this time to ascribe this weight-maintaining effect to a hormone with any certainty, since it is recognized that the demonstration of a substance of possibly hormonal nature conventionally rests upon the finding of its differential potency at increasing dose levels. Attempts to assay patients' plasma at doses greater than 0.9 ml. per rat per day in this study proved impractical since the larger amounts resulted in the death of nearly all the test animals. Construction of a dose-response curve must await purification of plasma.
A number of substances might be implicated to explain the partial maintenance of adrenal weight observed in these studies: 1) steroids of the adrenal cortex, 2) corticotropin, and 3) growth hormone. Certain steroids have been shown to cause increases in adrenal weight (22, 23) , but in the present study it seems unlikely that elevated plasma adrenal steroid levels were responsible for the observed increase in adrenal weight. In the first place, no adrenal weight increase was induced by the plasma from patients with adrenal cortical tumors whose resting plasma corticosteroid levels were as high as or higher than those of patients with adrenal hyperplasia.5 Second, adrenal weight-maintaining activity was found in plasma of two patients who had undergone bilateral adrenalectomy before the assay was carried out. Third, cortisone (a prototype of the class of steroid elevated to the greatest degree in Cushing's syndrome) has been shown to have no weight-augmenting effect upon adrenals of hypophysectomized rats (23) .
Corticotropin has also been suspected as a possible etiologic factor in bilateral adrenal hyperplasia. Although some workers have claimed to find corticotropin in the plasma of such patients (24, 25) most observers have failed to detect increased amounts of this substance by a variety of assay procedures (4-7). Furthermore, administration of the usual commercial preparations of ACTH has not been shown to cause the degree of adrenal cortical hyper-response found in patients with adrenal hyperplasia (8, 9) . 5Average plasma 17-OH-corticosteroid levels in 15 patients with bilateral adrenal hyperplasia, 29 micrograms per 100 ml.; average level in six patients with adrenal cortical tumor, 43 micrograms per 100 ml. (9) .
Since it seems unlikely that either adrenal steroids or ACTH can account for the observed adrenal weight-maintaining activity, the question of a possible role of other hormones may be raised. Liddle, Island, Rinfret, and Forsham (26) studied a material prepared by Rinfret from equine pituitaries which exhibited adrenal weight-maintaining activity and was capable of enhancing the sensitivity of the human adrenal cortex to "orthodox" ACTH, as measured by excretion of urinary corticosteroids. This equine pituitary extract in itself had very little steroidogenic effect. It is not known whether or not the weight-maintaining "substance" in plasma of patients with adrenal hyperplasia has the property of enhancing the steroidogenic effect of ordinary ACTH upon the adrenal cortex.
Adrenal weight-maintaining effects have been found in growth hormone fractions by Reinhardt, Geschwind, and Li (10), Young and his associates (11) , and Cater and Stack-Dunne (12) . In the study reported here, growth hormone showed partial adrenal weight-maintaining activity as did the plasma of two patients with acromegaly in whose blood one might expect to find excessive somatotropin (27) . It will be recalled that these two acromegalic patients did not show adrenal cortical hyper-response to ACTH.
The finding of adrenal weight-maintaining activity in the plasma of pregnant women in the third trimester is of interest in view of the alleged hyperresponsiveness of the adrenal cortex (2). The relationship, if any, between the two observations is not clear. It may perhaps be relevant that increased growth hormone levels have been found by Contopoulos and Simpson (28) in blood of pregnant rats, and that Cater and Stack-Dunne (12) have detected adrenal weight-maintaining activity in human placental extracts. No claim can be made on the basis of the data presented that either the adrenal hypersensitivity or the adrenal weight-maintaining activity in human pregnancy blood is or is not related to growth hormone. Furthermore, with our limited knowledge, it is impossible to decide at this time whether the adrenal weight-maintaining activity found in Cushing's syndrome with adrenal hyperplasia, acromegaly, and pregnancy is due to the same substance or to different substances. SUMMARY 1. Adrenal weight-maintaining activity was detected in plasma of patients with Cushing's syndrome due to bilateral adrenal hyperplasia. The assay used was the prevention of complete adrenal atrophy in hypophysectomized rats. No adrenal weight-maintaining activity was found in plasma of three patients with Cushing's syndrome due to adrenal tumor, in normal subjects, or in a pool of plasma from patients with primary adrenal cortical insufficiency.
2. Adrenal weight-maintaining activity was observed in three pools of plasma from women in the third trimester of pregnancy and in two patients with active acromegaly.
3. On the basis of this study, no statement can be made concerning the nature or origin of the substance or substances responsible for adrenal weight-maintaining activity in bilateral adrenal hyperplasia, late pregnancy, or active acromegaly.
